What is the normal reference interval for serum copper according to ARUP Laboratories?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Serum Copper Reference Intervals

The normal serum copper reference interval varies by age, sex, and physiological state, but for general adult populations, serum copper typically ranges from approximately 10-25 µmol/L (or 63-159 µg/dL), with specific variations based on laboratory methods and patient demographics 1.

Age-Specific Reference Intervals

Serum copper concentrations vary substantially with age, particularly in early life:

  • Neonates (0-<6 days): 1.9-15.4 µmol/L
  • Infants (6 days to <12 months): 6.5-26.9 µmol/L
  • Children (12 months to <7 years): 9.3-35.8 µmol/L
  • Older children/adolescents (7 to <19 years): 7.9-22.6 µmol/L 2

These age-specific intervals are critical because using overly broad age ranges can lead to misclassification, especially in pediatric populations where copper metabolism changes rapidly during development.

Adult Reference Intervals

For healthy non-pregnant adults, comprehensive NHANES data analysis provides reliable reference intervals that account for multiple variables 1. Sex-specific differences exist but are less pronounced than age-related variations in children 2.

Important Clinical Context

Factors Affecting Serum Copper Levels

Serum copper concentrations are influenced by:

  • Age and sex (most significant in pediatrics)
  • Pregnancy and oral contraceptive use (substantially elevate copper)
  • Ethnicity
  • Health status and smoking (in males)
  • Ceruloplasmin levels (approximately 90-95% of serum copper is bound to ceruloplasmin) 1

Critical Caveats for Interpretation

In Wilson's disease specifically, total serum copper is paradoxically usually decreased despite being a copper overload disorder, because it decreases proportionally with the low ceruloplasmin 3, 4. However:

  • In severe liver injury, serum copper may be within the normal range
  • In acute liver failure from Wilson's disease, serum copper may be markedly elevated due to sudden release from hepatic stores 3, 4

The key diagnostic parameter is non-ceruloplasmin-bound copper (free copper), calculated as:

  • Total serum copper (µg/L) - (3.15 × ceruloplasmin in mg/L) = non-ceruloplasmin-bound copper (µg/L)
  • Normal non-ceruloplasmin-bound copper: <200 µg/L (<25 µg/dL or <150 µg/L)
  • Elevated in Wilson's disease: >200 µg/L (>250 µg/L) 3, 4

Pre-analytical Considerations

Sample handling is crucial for accurate copper measurement:

  • Uncentrifuged serum shows time-dependent increases in exchangeable copper, exceeding acceptable variation after 4 hours 5
  • Long-term stability at -20°C is limited to approximately 1.7 months 5
  • Contamination from collection devices can falsely elevate results

Laboratory-Specific Variations

Reference intervals must be validated for each laboratory's specific methodology because analytical methods vary significantly. The establishment of candidate reference methods using ICP-MS aims to improve standardization and harmonization across laboratories 6. ARUP Laboratories and other reference labs should provide their own validated intervals based on their analytical platform and local population characteristics.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.